Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
04 April 2019 | Story Ruan Bruwer | Photo Varsity Cup
Lubabalo Dobela
Flyhalf Lubabalo Dobela will be an important cog in the wheel for the Shimlas against the Maties in the semi-final stage of the Varsity Cup. He has been named Player that Rocks twice this year.
The Shimlas (University of the Free State) will go into the semi-final against the unbeaten Maties with confidence, knowing that they can compete against them, said coach Hendro Scholtz.

The Shimlas will travel to Stellenbosch for the Varsity Cup clash on Monday (8 April). They qualified for the play-offs thanks to a 38-14 victory over the University of Johannesburg (UJ) in the final round of the competition on Monday 1 April 2019.

The Free State students lost to the Maties by 59-14 two weeks ago, and although the score reflects a big hiding, the Shimlas stood tall for most of the encounter.

“With 18 minutes remaining, we trailed by only ten points (14-24). We can gain confidence from that. We learned a couple of things about them. We will have to stop their driving mall and be sharp when it comes to our discipline. They will hurt us if we concede penalties,” said Scholtz.

According to him, it is important to get off to a good start. “You often sit with students who have other things to think about apart from rugby, such as upcoming tests, which can hamper their concentration. Against UJ in the wet, it was important to play the conditions right, and I think it made the players concentrate that little bit more.”

The Shimlas won four of their eight group matches and will look back on their defeats against the Pukke and Ixias as matches that they could easily have won on another day.

It is the fifth time in the 12 years of the Varsity Cup that the Shimlas have reached the final-four stage, with one win in 2015 over the Ikeys.

The Shimlas will be without two of their key men among the forwards – the injured flank Janco Cloete and hooker Hanno Snyman.

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept